Filizoğlu, N. Et Al. 2022. Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.. Molecular imaging and radionuclide therapy , vol.31, no.3 , 234-236.

Filizoğlu, N., Öksüzoğlu, K., Özgüven, S., Buğdaycı, O., & Erdil, T. Y., (2022). Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.. Molecular imaging and radionuclide therapy , vol.31, no.3, 234-236.

Filizoğlu, Nuh Et Al. "Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.," Molecular imaging and radionuclide therapy , vol.31, no.3, 234-236, 2022

Filizoğlu, Nuh Et Al. "Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.." Molecular imaging and radionuclide therapy , vol.31, no.3, pp.234-236, 2022

Filizoğlu, N. Et Al. (2022) . "Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.." Molecular imaging and radionuclide therapy , vol.31, no.3, pp.234-236.

@article{article, author={Nuh Filizoğlu Et Al. }, title={Nasolacrimal Duct Obstruction on (131)I SPECT/CT: Atypical False-positive Paranasal Radioiodine Uptake as a Complication of Single-dose RAI Treatment.}, journal={Molecular imaging and radionuclide therapy}, year=2022, pages={234-236} }